Czech Republic orders 5.5M doses of COVID-19 vaccine
In a joint agreement between the European Union states, the Czech Republic has ordered 5.5 million doses of covid-19 vaccine from three manufacturers at the cost of 1.8 billion crowns. It is negotiating millions more with other manufacturers.
EU countries are negotiating the supply of a vaccine with seven manufacturers. They only have to buy them if they pass all the tests and are approved. Vaccinations in the Czech Republic should then be covered by public health insurance, voluntary and preferential for risk groups and health professionals, social workers, and other essential occupations for the state.
“Vaccines for up to another 10.6 million inhabitants are in reserve from other manufacturers. We should have it for up to 16 million people, which is more than the Czech Republic population. It is an approach that other countries have adopted,” said the minister. . According to him, a vaccination strategy will be submitted to the government within two weeks, which will set out the procedure for the order of different groups of the population in vaccination.
From the material for the government meeting, which is available to ČTK, three million doses for the vaccination of 1.5 million people were ordered from Astra Zeneca. Two doses to induce immunity will also be needed for the vaccine from BioNTech and Pfizer, which the Czechia should have for two million people. A vaccine has been ordered from Johnson & Johnson for the same number of people, and so far, there is no order from Sanofi.
According to the timetable set out in the material, benefits for 400,000 people should arrive at the end of 2020. One of the vaccines is approved, 850,000 people in the first quarter of next year, and 2.1 million in the second and 3 million in the third quarter. , 9 million people and in the last quarter of next year for 250,000 people.
According to the material, the commission also deals with a vaccine for a maximum of 2.56 million people from Curevac, for a maximum of 950,000 people from Moderna, and up to 3.5 million people from Novavax also produces part of the vaccine in the Czech Republic. In total, they could supply the vaccine to up to 10.6 million people for 4.6 billion crowns. According to the schedule, most of them would be available in the second half of next year.
A formal application for approval of the first vaccine from BioNTech / Pfizer is expected by the end of November. It would then be approved by the end of the year, according to the material prepared by the Ministry of Health. The first delivery should then be within eight to nine weeks. The Czech Republic must send the binding order by 15 December from Johnson & Johnson by the end of the year. The Czech Republic has bindingly ordered from the Astra Zeneca company. “The obligations to which the Czech Republic has already committed itself imply an obligation to issue binding orders worth CZK 1.72 billion during December of this year,” the document said.
According to the published draft of the National Vaccination Strategy against covid-19, prepared by the Ministry under the previous leadership, people over 65 years of age who suffer from chronic lung disease, high blood pressure that cannot be reduced by drugs, serious heart and kidney diseases should be vaccinated first. Or liver, severe obesity, severe diabetes, or some cancer treatment, such as radiotherapy, chemotherapy, or immunosuppression.
The first phase also envisages vaccinating ARO, ICU, emergency departments, infectious and lung departments, emergency services, public health workers performing epidemiological investigations, laboratory staff testing covid-19, and social service staff and clients.
In the second phase, general or pediatric general practitioners, dentists or pharmacists, and staff from the integrated rescue system, other staff of public health authorities, critical infrastructure, members of crisis staff, or the government could be vaccinated. In the last phase, the vaccine would be available to others.